Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Association of Cohort and Individual Substance Use With Risk of Transitioning to Drug Use, Drug Use Disorder, and Remission From Disorder: Findings From the World Mental Health Surveys.

Degenhardt L, Bharat C, Glantz MD, Sampson NA, Al-Hamzawi A, Alonso J, Andrade LH, Bunting B, Cia A, de Girolamo G, De Jonge P, Demyttenaere K, Gureje O, Haro JM, Harris MG, He Y, Hinkov H, Karam AN, Karam EG, Kiejna A, Kovess-Masfety V, Lasebikan V, Lee S, Levinson D, Medina-Mora ME, Mneimneh Z, Navarro-Mateu F, Piazza M, Posada-Villa J, Scott K, Stein DJ, Tachimori H, Tintle N, Torres Y, Kessler RC; WHO World Mental Health Survey Collaborators.

JAMA Psychiatry. 2019 Mar 13. doi: 10.1001/jamapsychiatry.2019.0163. [Epub ahead of print]

PMID:
30865282
2.

The impact of cohort substance use upon likelihood of transitioning through stages of alcohol and cannabis use and use disorder: Findings from the Australian National Survey on Mental Health and Wellbeing.

Degenhardt L, Glantz M, Bharat C, Peacock A, Lago L, Sampson N, Kessler RC.

Drug Alcohol Rev. 2018 May;37(4):546-556. doi: 10.1111/dar.12679. Epub 2018 Mar 5.

PMID:
29505682
3.

Cross-sectional Comparison of the Epidemiology of DSM-5 Generalized Anxiety Disorder Across the Globe.

Ruscio AM, Hallion LS, Lim CCW, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Andrade LH, Borges G, Bromet EJ, Bunting B, Caldas de Almeida JM, Demyttenaere K, Florescu S, de Girolamo G, Gureje O, Haro JM, He Y, Hinkov H, Hu C, de Jonge P, Karam EG, Lee S, Lepine JP, Levinson D, Mneimneh Z, Navarro-Mateu F, Posada-Villa J, Slade T, Stein DJ, Torres Y, Uda H, Wojtyniak B, Kessler RC, Chatterji S, Scott KM.

JAMA Psychiatry. 2017 May 1;74(5):465-475. doi: 10.1001/jamapsychiatry.2017.0056.

4.

Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys.

Seedat S, Scott KM, Angermeyer MC, Berglund P, Bromet EJ, Brugha TS, Demyttenaere K, de Girolamo G, Haro JM, Jin R, Karam EG, Kovess-Masfety V, Levinson D, Medina Mora ME, Ono Y, Ormel J, Pennell BE, Posada-Villa J, Sampson NA, Williams D, Kessler RC.

Arch Gen Psychiatry. 2009 Jul;66(7):785-95. doi: 10.1001/archgenpsychiatry.2009.36.

5.

Association of DSM-IV Posttraumatic Stress Disorder With Traumatic Experience Type and History in the World Health Organization World Mental Health Surveys.

Liu H, Petukhova MV, Sampson NA, Aguilar-Gaxiola S, Alonso J, Andrade LH, Bromet EJ, de Girolamo G, Haro JM, Hinkov H, Kawakami N, Koenen KC, Kovess-Masfety V, Lee S, Medina-Mora ME, Navarro-Mateu F, O'Neill S, Piazza M, Posada-Villa J, Scott KM, Shahly V, Stein DJ, Ten Have M, Torres Y, Gureje O, Zaslavsky AM, Kessler RC; World Health Organization World Mental Health Survey Collaborators.

JAMA Psychiatry. 2017 Mar 1;74(3):270-281. doi: 10.1001/jamapsychiatry.2016.3783. Erratum in: JAMA Psychiatry. 2017 Jul 1;74(7):764.

6.

Estudio epidemiológico de sucesos traumáticos, trastorno de estrés post-traumático y otros trastornos psiquiátricos en una muestra representativa de Chile.

Pérez Benítez CI, Vicente B, Zlotnick C, Kohn R, Johnson J, Valdivia S, Rioseco P.

Salud Ment (Mex). 2009 Jan 1;32(2):145-153. Spanish.

7.

Changes in US Lifetime Heroin Use and Heroin Use Disorder: Prevalence From the 2001-2002 to 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions.

Martins SS, Sarvet A, Santaella-Tenorio J, Saha T, Grant BF, Hasin DS.

JAMA Psychiatry. 2017 May 1;74(5):445-455. doi: 10.1001/jamapsychiatry.2017.0113. Erratum in: JAMA Psychiatry. 2017 Oct 1;74(10):1079.

8.

The associations between psychotic experiences and substance use and substance use disorders: findings from the World Health Organization World Mental Health surveys.

Degenhardt L, Saha S, Lim CCW, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Andrade LH, Bromet EJ, Bruffaerts R, Caldas-de-Almeida JM, de Girolamo G, Florescu S, Gureje O, Haro JM, Karam EG, Karam G, Kovess-Masfety V, Lee S, Lepine JP, Makanjuola V, Medina-Mora ME, Mneimneh Z, Navarro-Mateu F, Piazza M, Posada-Villa J, Sampson NA, Scott KM, Stagnaro JC, Ten Have M, Kendler KS, Kessler RC, McGrath JJ; WHO World Mental Health Survey Collaborators.

Addiction. 2018 May;113(5):924-934. doi: 10.1111/add.14145. Epub 2018 Feb 21.

PMID:
29284197
9.

Birth-sex cohort alcohol use transitions in the general population: the cross-sectional PEGASUS-Murcia project.

Husky MM, Bharat C, Vilagut G, Salmerón D, Martínez S, Navarro C, Alonso J, Kessler RC, Navarro-Mateu F.

Adicciones. 2018 Dec 20;0(0):1067. doi: 10.20882/adicciones.1067. [Epub ahead of print] English, Spanish.

10.

Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, Zhang H, Smith SM, Pickering RP, Huang B, Hasin DS.

JAMA Psychiatry. 2016 Jan;73(1):39-47. doi: 10.1001/jamapsychiatry.2015.2132.

11.

Use and abuse of alcohol and illicit drugs in US adolescents: results of the National Comorbidity Survey-Adolescent Supplement.

Swendsen J, Burstein M, Case B, Conway KP, Dierker L, He J, Merikangas KR.

Arch Gen Psychiatry. 2012 Apr;69(4):390-8. doi: 10.1001/archgenpsychiatry.2011.1503.

12.

Transitions between lifetime alcohol use, regular use and remission: Results from the 2004 South African Stress and Health Survey.

Harker Burnhams N, Bharat C, Williams DR, Stein DJ, Myers B.

S Afr Med J. 2018 Dec 13;109(1):40-46. doi: 10.7196/SAMJ.2018.v109i1.13061.

PMID:
30606303
14.

Association of Fluid Intelligence and Psychiatric Disorders in a Population-Representative Sample of US Adolescents.

Keyes KM, Platt J, Kaufman AS, McLaughlin KA.

JAMA Psychiatry. 2017 Feb 1;74(2):179-188. doi: 10.1001/jamapsychiatry.2016.3723.

15.

Lifetime and 12-month prevalence, severity and unmet need for treatment of common mental disorders in Japan: results from the final dataset of World Mental Health Japan Survey.

Ishikawa H, Kawakami N, Kessler RC; World Mental Health Japan Survey Collaborators.

Epidemiol Psychiatr Sci. 2016 Jun;25(3):217-29. doi: 10.1017/S2045796015000566. Epub 2015 Jul 7.

16.

Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO's World Mental Health Surveys.

Degenhardt L, Bharat C, Bruno R, Glantz MD, Sampson NA, Lago L, Aguilar-Gaxiola S, Alonso J, Andrade LH, Bunting B, Caldas-de-Almeida JM, Cia AH, Gureje O, Karam EG, Khalaf M, McGrath JJ, Moskalewicz J, Lee S, Mneimneh Z, Navarro-Mateu F, Sasu CC, Scott K, Torres Y, Poznyak V, Chatterji S, Kessler RC; WHO World Mental Health Survey Collaborators.

Addiction. 2019 Mar;114(3):534-552. doi: 10.1111/add.14482. Epub 2018 Dec 9.

PMID:
30370636
17.

Association of Mental Disorders With Subsequent Chronic Physical Conditions: World Mental Health Surveys From 17 Countries.

Scott KM, Lim C, Al-Hamzawi A, Alonso J, Bruffaerts R, Caldas-de-Almeida JM, Florescu S, de Girolamo G, Hu C, de Jonge P, Kawakami N, Medina-Mora ME, Moskalewicz J, Navarro-Mateu F, O'Neill S, Piazza M, Posada-Villa J, Torres Y, Kessler RC.

JAMA Psychiatry. 2016 Feb;73(2):150-8. doi: 10.1001/jamapsychiatry.2015.2688.

18.

Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study.

McCabe SE, West BT, Morales M, Cranford JA, Boyd CJ.

Addiction. 2007 Dec;102(12):1920-30. Epub 2007 Oct 4.

19.

Association Between Psychotic Experiences and Subsequent Suicidal Thoughts and Behaviors: A Cross-National Analysis From the World Health Organization World Mental Health Surveys.

Bromet EJ, Nock MK, Saha S, Lim CCW, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Borges G, Bruffaerts R, Degenhardt L, de Girolamo G, de Jonge P, Florescu S, Gureje O, Haro JM, He Y, Hu C, Karam EG, Kovess-Masfety V, Lee S, Lepine JP, Mneimneh Z, Navarro-Mateu F, Ojagbemi A, Posada-Villa J, Sampson NA, Scott KM, Stagnaro JC, Viana MC, Xavier M, Kessler RC, McGrath JJ; World Health Organization World Mental Health Survey Collaborators.

JAMA Psychiatry. 2017 Nov 1;74(11):1136-1144. doi: 10.1001/jamapsychiatry.2017.2647.

20.

Sociodemographic predictors of transitions across stages of alcohol use, disorders, and remission in the National Comorbidity Survey Replication.

Kalaydjian A, Swendsen J, Chiu WT, Dierker L, Degenhardt L, Glantz M, Merikangas KR, Sampson N, Kessler R.

Compr Psychiatry. 2009 Jul-Aug;50(4):299-306. doi: 10.1016/j.comppsych.2008.09.012. Epub 2008 Nov 22.

Supplemental Content

Support Center